RCEL

#3760
Avita Medical, Inc. Common Stock
5.60 USD
+14.05%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
5.60
5.60
1年のレンジ
3.22
10.29
1日の変化
+14.05%
月次変化
+21.21%
6か月変化
+6.87%
1年の変化
-35.33%
以前の終値
4.91
始値
5.60
Bid
Ask
安値
5.60
High
5.60
ボリューム
22
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 171.54 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.98
売上高対価格比率
1.34

Avita Medical Inc

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

ニュース